These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 23670484)
1. Telaprevir and boceprevir: a potential role for therapeutic drug monitoring. Dolton MJ; Ray JE; McLachlan AJ Ther Drug Monit; 2013 Jun; 35(3):414-5. PubMed ID: 23670484 [No Abstract] [Full Text] [Related]
2. Directly acting antivirals for hepatitis C and antiretrovirals: potential for drug-drug interactions. Seden K; Back D Curr Opin HIV AIDS; 2011 Nov; 6(6):514-26. PubMed ID: 22001895 [TBL] [Abstract][Full Text] [Related]
3. A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C. Jacobson IM; Pawlotsky JM; Afdhal NH; Dusheiko GM; Forns X; Jensen DM; Poordad F; Schulz J J Viral Hepat; 2012 May; 19 Suppl 2():1-26. PubMed ID: 22404758 [TBL] [Abstract][Full Text] [Related]
4. Direct-acting antiviral (DAA) actions in treatment-naïve patients. Hézode C Clin Res Hepatol Gastroenterol; 2011 Dec; 35 Suppl 2():S52-8. PubMed ID: 22248695 [TBL] [Abstract][Full Text] [Related]
5. The first wave: HCV NS3 protease inhibitors telaprevir and boceprevir. Marks KM; Jacobson IM Antivir Ther; 2012; 17(6 Pt B):1119-31. PubMed ID: 23188750 [TBL] [Abstract][Full Text] [Related]
6. Protease inhibitors in hepatitis C: from chronic disease to cure. Iqbal M; McCormick PA Ir Med J; 2011 Sep; 104(8):230-1. PubMed ID: 22125874 [No Abstract] [Full Text] [Related]
7. [Therapy of hepatitis C: new inhibitors as hammers against HCV]. Bublak R MMW Fortschr Med; 2013 Jun; 155 Suppl 1():10-1. PubMed ID: 23961643 [No Abstract] [Full Text] [Related]
8. [A new era in therapy of hepatitis C: "the therapy can now be individualized" (interview by Dr. med. Dirk Einecke)]. Manns M MMW Fortschr Med; 2011 Jul; 153(29-31):17. PubMed ID: 21830729 [No Abstract] [Full Text] [Related]
9. Future of hepatitis C therapy: development of direct-acting antivirals. Dore GJ; Matthews GV; Rockstroh J Curr Opin HIV AIDS; 2011 Nov; 6(6):508-13. PubMed ID: 21897228 [TBL] [Abstract][Full Text] [Related]
10. Update on the use of direct-acting antiviral agents for the treatment of chronic hepatitis C virus infection. Fernández-Yunquera A; Rincón D; Salcedo M; Bañares R Rev Esp Quimioter; 2013 Sep; 26(3):189-92. PubMed ID: 24080883 [No Abstract] [Full Text] [Related]
11. New developments in HCV therapy. Kronenberger B; Zeuzem S J Viral Hepat; 2012 Jan; 19 Suppl 1():48-51. PubMed ID: 22233414 [TBL] [Abstract][Full Text] [Related]
12. Infectious diseases. First specific drugs raise hopes for hepatitis C. Enserink M Science; 2011 Apr; 332(6026):159-60. PubMed ID: 21474720 [No Abstract] [Full Text] [Related]
13. Antiviral agents and hepatitis C. Archer-Festa M; Nilsen-Kupsch S N Y State Dent J; 2012; 78(4):42-5. PubMed ID: 23252194 [TBL] [Abstract][Full Text] [Related]
14. The importance of drug-drug interactions in the DAA era. Back D; Else L Dig Liver Dis; 2013 Sep; 45 Suppl 5():S343-8. PubMed ID: 24091114 [TBL] [Abstract][Full Text] [Related]
15. Boceprevir and telaprevir in the management of hepatitis C virus-infected patients. Butt AA; Kanwal F Clin Infect Dis; 2012 Jan; 54(1):96-104. PubMed ID: 22156853 [TBL] [Abstract][Full Text] [Related]
16. [Future of antiviral therapy for chronic hepatitis C. Direct antiviral acting medications]. Lange CM; Sarrazin C; Zeuzem S Pharm Unserer Zeit; 2011 Jan; 40(1):60-7. PubMed ID: 21194084 [No Abstract] [Full Text] [Related]
17. [New times for the treatment of chronic hepatitis C]. Gerstoft J; Fomsgaard A Ugeskr Laeger; 2012 Mar; 174(12):795. PubMed ID: 22433552 [No Abstract] [Full Text] [Related]
18. The FDA, bridging data, and hepatitis C. Fried MW; Jensen DM Hepatology; 2013 Mar; 57(3):875-7. PubMed ID: 23456679 [No Abstract] [Full Text] [Related]
19. [Boceprevir and telaprevir utilization: evaluation for the treatment of chronic hepatitis C]. Marrero-Álvarez P; Gil-Gómez I; Monte-Boquet E; Lorente-Fernández L; Poveda-Andrés JL Farm Hosp; 2014 Jan; 38(1):30-7. PubMed ID: 24483857 [TBL] [Abstract][Full Text] [Related]
20. Two drugs approved for chronic hepatitis C infection. Traynor K Am J Health Syst Pharm; 2011 Jul; 68(13):1176. PubMed ID: 21690418 [No Abstract] [Full Text] [Related] [Next] [New Search]